2675.HK

MedTech

Shenzhen Edge Medical

Surgical robotics — laparoscopic and endoscopic systems

37.86

▼ 1.10 (-2.82%)

Needs attentionPrice 80% above estimated priceEBIT covers interest only -162.8× — operating profit does not cover the interest bill.Trailing-margin DCF likely understates value — the company is scaling into first profitability (trailing EBITDA is negative), so a forecast anchored to last year's margin is conservative. Review with Level-3 assumptions.Terminal value is 92% of enterprise value — most of this DCF rests on far-future assumptions. Weight the peer cross-check accordingly.Thinly traded (~0.068% of shares/day) — the market price is a weak benchmark for this valuation gap.

Price · volume · estimated price

Chart

37.86

Jul 29, 2026 · Vol 167.4K

Thesis

At a glance

Shenzhen-based surgical-robotics developer listed on HKEX under Chapter 18A. Commercial and scaling: FY2025 revenue RMB 455.7m (+184.8%), gross margin above 58%, net loss narrowed 59.4% to RMB 88.6m. Monitoring-only pending the financials adapter and an RMB/HKD decision, not because it is pre-revenue.

Market signals · technical

Price & volume signals

Technical signals from price history, for your own read of market timing. These never affect the Estimated Price — they sit apart from the valuation by design.

Trend

n/a

price vs SMAs

RSI (14)

n/a

Volume trend

n/a

10 vs prior 10

SMA 20

n/a

SMA 50

n/a

SMA 200

n/a

· Only 6 bars — the 50/200-day averages need more history.

Estimated Price3-level modelrecomputed live

7.51-80.18% vs 37.86

Reported in CNY, shown in HKD · CNY→HKD 1.1560 as of 2026-07-23

Trailing-margin DCF likely understates value — the company is scaling into first profitability (trailing EBITDA is negative), so a forecast anchored to last year's margin is conservative. Review with Level-3 assumptions.

Terminal value is 92% of enterprise value — most of this DCF rests on far-future assumptions. Weight the peer cross-check accordingly.

L1DCF core

WACC 8.95% · β 0.95

7.51

L2Peer check · no adjustment

peer cross-check N/A — no same-market peer set

7.51

L3Manual override

none — using the rule

—

WACC build-up

Cost of equity (CAPM)8.95%

After-tax cost of debt4.32%

Equity / debt weight99.92% / 0.08%

WACC8.95%

Level 2 · cross-check

Not applicable — no same-market peer set for this listing. The DCF is not cross-checked against unrelated-market multiples.

No reliability rule firing — Level 1 passes through.

Leverage & debt serviceability

Total debt$9.9M

Net debt−$76.2M

Debt / revenue2.17%

Interest expense$541.0K

EBIT covers interest only -162.8× — operating profit does not cover the interest bill.

Serviceability lens (EBIT ÷ interest) — separate from the WACC and the leverage haircut; never moves the Estimated Price.

Valuation methods · side by side

DCF (intrinsic)low

7.51

Terminal value is 92% of enterprise value.

Peer P/Sn/a

n/a

no same-market peer set — not compared to another market's multiples

Shown side by side, never averaged. Headline uses the DCF, with the peer multiple as fallback when the DCF is invalid.

Trailing twelve months · from XBRL

Fundamentals

as of Dec 31, 2025

Revenue

$455.7M

Gross margin

65.97%

EBITDA

−$62.4M

EBITDA margin

-13.70%

Net income

−$88.6M

EPS

-0.25

Cash

$86.0M

Total debt

$9.9M

Net debt

−$76.2M

Net leverage

—

Book value

$1.20B

Backlog

—

Position

No open position. Record a trade on the Portfolio tab and it flows into this card.

Company status agent

Status

No status generated yet. The status agent writes here when new data lands.

EDGAR · diffed daily

Filings & extraction

Completion of change of registered addressJul 29, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Voluntary announcement investment in primalverseJul 24, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnJul 22, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Monthly Return of Equity Issuer on Movements in Sec…Jul 07, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnJul 02, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.

View all filings (+39) ▾

Next Day Disclosure ReturnJun 26, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Articles of associationJun 25, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Poll results of the annual general meeting held on…Jun 25, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnJun 24, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnJun 23, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnJun 22, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnJun 18, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnJun 16, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnJun 12, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Voluntary announcement intention to conduct on-mark…Jun 09, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Monthly Return of Equity Issuer on Movements in Sec…Jun 04, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Proxy Form for the Annual General Meeting to be hel…Jun 03, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Notice of the annual general meetingJun 03, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Circular for Annual General MeetingJun 03, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Proposed amendments to the articles of associationJun 01, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Monthly Return of Equity Issuer on Movements in Sec…May 07, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
2025 annual reportApr 28, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Edge Medical ESG Report 2025Apr 28, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Monthly Return of Equity Issuer on Movements in Sec…Apr 08, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Annual results announcement for the year ended dece…Mar 27, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Notice of board meetingMar 17, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Notification Letter to Registered H Shareholders -…Mar 11, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Notification Letter to Non-registered Holders of H…Mar 11, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Monthly Return of Equity Issuer on Movements in Sec…Mar 04, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Next Day Disclosure ReturnFeb 09, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Monthly Return of Equity Issuer on Movements in Sec…Feb 05, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Full exercise of the over-allotment option, stabili…Feb 04, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
List of directors and their roles and functionsJan 07, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Announcement of allotment resultsJan 07, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Terms of reference of the nomination committee of t…Jan 07, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Terms of reference of the audit committee of the bo…Jan 07, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Articles of associationJan 07, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Terms of reference of the remuneration committee of…Jan 07, 2026unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Global offeringDec 30, 2025unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Documents on DisplayDec 30, 2025unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
Global offeringDec 30, 2025unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
PHIP (1st submission)Dec 21, 2025unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
OC Announcement - AppointmentDec 21, 2025unprocessed
Source ↗
Facts ingested; qualitative extraction pending.
PHIP (1st submission)Dec 21, 2025unprocessed
Source ↗
Facts ingested; qualitative extraction pending.

Review queue · nothing auto-saves

News & signals

9 queued

neutralmedium magnitudemedium-termhkexnewstoday
Notification Letter to Registered H Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
HKEXnews: Circulars - [Other]. Awaiting human review.
Source ↗
neutralmedium magnitudemedium-termhkexnewstoday
Notification Letter to Non-registered Holders of H Shares and Request Form - Arrangement of Electronic Dissemination of Corporate Communications
HKEXnews: Circulars - [Other]. Awaiting human review.
Source ↗
neutralmedium magnitudemedium-termhkexnewstoday
NOTICE OF BOARD MEETING
HKEXnews: Announcements and Notices - [Date of Board Meeting]. Awaiting human review.
Source ↗
neutralmedium magnitudemedium-termhkexnewstoday
VOLUNTARY ANNOUNCEMENT INVESTMENT IN PRIMALVERSE
HKEXnews: Announcements and Notices - [Other - Business Update]. Awaiting human review.
Source ↗
neutralhigh magnitudemedium-termhkexnewstoday
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025
HKEXnews: Announcements and Notices - [Final Results]. Awaiting human review.
Source ↗

Illustrative data where noted. Not investment advice.